Procurement of raw materials and services and distribution of drugs is a global reality for the biopharma and medical device industry. On the positive side, it has enabled our industry to provide life-giving medicines to millions of patients. However, the significant challenges and responsibilities of securing and protecting the integrity of the vast, global pharmaceutical supply chain affect all drug developers and suppliers – small, medium and large in size. New laws, regulations and guidance continue to stimulate innovation toward enhancing good manufacturing, distribution, and importation practices. This presentation will discuss an international network to provide economical QA audit of suppliers across the globe, and implementation of innovative approaches to protect the quality of the product to the patient and to prevent illicit acts such as counterfeiting, diversion, and economic adulteration from threatening the safety of the drug supply.
Martin VanTrieste
SVP, Quality
Amgen Inc.
Martin VanTrieste is the senior vice president of Quality at Amgen. He is responsible for all aspects of Quality Assurance, Quality Control, Compliance, Operational Excellence,
Environment, Health and Safety along with Training at Amgen.
Prior to joining Amgen, VanTrieste was with Bayer HealthCare’s Biological Products Division as vice president of Worldwide Quality and Abbott Laboratories as the vice president of Quality Assurance for the Hospital Products Division. While at Abbott, VanTrieste held various positions in Quality, Operations, and Research and Development. He started his career at Abbott in 1983 after obtaining his Pharmacy degree from Temple University School of Pharmacy.
VanTrieste has been actively involved with various professional and trade organizations, including United States Pharmacopeia (USP), Pharmaceutical Quality Research Institute
(PQRI), Pharmaceutical Research and Manufacturers of America (PhRMA), and AdvaMed,and he is a member of the Board of Directors of the Parenteral Drug Associations (PDA). He is the founder and first Chairman of Rx-360 and is currently on their Board of Directors. Rx-360 is a nonprofit international supply chain organization that will enhance patient safety by increasing the security and quality of all parts of the supply chain. PharmaVoice in 2012 named VanTrieste one of the 100 most inspiring people in the pharmaceutical industry and call him “a man with a mission”.
About Rx-360
Rx-360 is an international consortium of pharmaceutical, biotech and medical device companies and suppliers. Rx-360’s mission is to protect patient safety by sharing information and developing processes related to the integrity of the healthcare supply chain and the quality of materials within the supply chain. Rx-360 was formed in 2009 to support an industry-wide commitment to ensuring patient safety by enhancing quality and authenticity throughout the supply chain. The mission of the organization is timely in light of growing attacks and threats to an increasingly complex and global supply chain. Millions of people around the world are treated every day with the vital medicines that pharmaceutical and biotechnology companies provide. Management of the pharmaceutical supply chain has become one of the top public health concerns with respect to consumer safety. The globalization of distribution for both drug components and finished products has introduced many complications that Rx-360 is positioned to help resolve. To learn more about Rx-360, go to www.Rx-360.org.
Pharma Sources Insight JANUARY 2024
